Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VTE (Venous Thromboembolism)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07654634
What this trial is testing

Precision Antithrombotic Therapy

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)MI(Myocardial Infarction)+1 more
The Third Xiangya Hospital of Central South University 5,000
Not applicableUnknownNCT05515549
What this trial is testing

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Who this might be right for
Venous Thromboembolic Disease
Qianfoshan Hospital 300
Large-scale testing (Phase 3)Study completedNCT04075240
What this trial is testing

VTE Prevention Following Total Hip and Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Sudeep Shivakumar 5,429
Large-scale testing (Phase 3)Study completedNCT02798471
What this trial is testing

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Pulmonary EmbolismDeep Vein Thrombosis (DVT)
Daiichi Sankyo 290
Not applicableEnded earlyNCT05966740
What this trial is testing

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 5
Large-scale testing (Phase 3)Study completedNCT00937820
What this trial is testing

Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 87
Testing effectiveness (Phase 2)Looking for participantsNCT04295486
What this trial is testing

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Who this might be right for
Venous Thromboembolism
University of Miami 5,478
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Large-scale testing (Phase 3)Ended earlyNCT02583191
What this trial is testing

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Who this might be right for
Venous ThromboembolismCancer
AIO-Studien-gGmbH 246
Not applicableStudy completedNCT03367364
What this trial is testing

Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis

Who this might be right for
Venous Thrombosis (Disorder)
Johns Hopkins University 9,657
Large-scale testing (Phase 3)Study completedNCT00697099
What this trial is testing

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 2,326
Large-scale testing (Phase 3)Looking for participantsNCT07213778
What this trial is testing

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Who this might be right for
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4
Not applicableEnded earlyNCT00789399
What this trial is testing

The Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

Who this might be right for
Deep Vein ThrombosisCoronary Artery Bypass SurgeryVenous Thromboembolism
Prairie Education and Research Cooperative 78
Post-approval studies (Phase 4)Study completedNCT01119300
What this trial is testing

EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

Who this might be right for
Venous ThromboembolismAtrial Fibrillation
Utrecht Institute for Pharmaceutical Sciences 455
Not applicableStudy completedNCT04963374
What this trial is testing

The Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients

Who this might be right for
Venous Thromboembolism
Peking University Third Hospital 100
Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Not applicableNot Yet RecruitingNCT07716332
What this trial is testing

Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis

Who this might be right for
PostpartumDVT Prophylaxis
Ron Beloosesky MD 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432529
What this trial is testing

Design and Rationale of the COLT Study

Who this might be right for
Venous Thrombosis Deep (Limbs)Post-thrombotic SyndromeVenous Thromboembolism (VTE)+1 more
Azienda Sanitaria Locale ASL 6, Livorno 940
Testing effectiveness (Phase 2)Study completedNCT00396786
What this trial is testing

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 877
Next Page